Anticholinergics (antimuscarinics)/ Anti-spasmodics
Glycopyrronium Bromide (Oral solution)
Glycopyrronium Bromide is indicated to reduce chronic severe drooling in patients aged 3 to 16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy).